Literature DB >> 29406530

Alternative devices for obstructive sleep apnea.

Daniel A Barone1.   

Abstract

Obstructive sleep apnea (OSA) is a relatively common condition which is most often treated with continuous positive airway pressure (CPAP). Given the compliance issues associated with CPAP, it is important for neurologists (and anyone who treats OSA) to be aware of what other treatment devices exist for this disease. This article reviews mandibular advancement devices, nasal expiratory airway pressure devices, hypoglossal nerve stimulators, and oral pressure therapy devices in terms of their mechanism of action, efficacy, and practicality.

Entities:  

Year:  2013        PMID: 29406530      PMCID: PMC5765942          DOI: 10.1212/CPJ.0b013e318278be88

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  9 in total

Review 1.  Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy.

Authors:  Marie Marklund; Johan Verbraecken; Winfried Randerath
Journal:  Eur Respir J       Date:  2011-11-10       Impact factor: 16.671

2.  Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA).

Authors:  Meir H Kryger; Richard B Berry; Clifford A Massie
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

3.  Compliance and efficacy of titratable thermoplastic versus custom mandibular advancement devices.

Authors:  Michael Friedman; Craig Hamilton; Christian G Samuelson; Kanwar Kelley; Kristine Pearson-Chauhan; David Taylor; Renwick Taylor; Alexander Maley; Martin A Hirsch
Journal:  Otolaryngol Head Neck Surg       Date:  2012-03-07       Impact factor: 3.497

4.  Treating obstructive sleep apnea with hypoglossal nerve stimulation.

Authors:  Peter R Eastwood; Maree Barnes; Jennifer H Walsh; Kathleen J Maddison; Geoffrey Hee; Alan R Schwartz; Philip L Smith; Atul Malhotra; R Douglas McEvoy; John R Wheatley; Fergal J O'Donoghue; Peter D Rochford; Tom Churchward; Matthew C Campbell; Carsten E Palme; Sam Robinson; George S Goding; Danny J Eckert; Amy S Jordan; Peter G Catcheside; Louise Tyler; Nick A Antic; Christopher J Worsnop; Eric J Kezirian; David R Hillman
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

5.  A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure.

Authors:  James K Walsh; Kara S Griffin; Elizabeth H Forst; Hasanali H Ahmed; Rhody D Eisenstein; Denise Troy Curry; Janine M Hall-Porter; Paula K Schweitzer
Journal:  Sleep Med       Date:  2011-01-21       Impact factor: 3.492

6.  Implanted upper airway stimulation device for obstructive sleep apnea.

Authors:  Paul H Van de Heyning; M Safwan Badr; Jonathan Z Baskin; Michel A Cramer Bornemann; Wilfried A De Backer; Yaniv Dotan; Winfried Hohenhorst; Lennart Knaack; Ho-Sheng Lin; Joachim T Maurer; Aviram Netzer; Rick M Odland; Arie Oliven; Kingman P Strohl; Olivier M Vanderveken; Johan Verbraecken; B Tucker Woodson
Journal:  Laryngoscope       Date:  2012-05-01       Impact factor: 3.325

7.  Non-CPAP therapies in obstructive sleep apnoea.

Authors:  W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze
Journal:  Eur Respir J       Date:  2011-03-15       Impact factor: 16.671

Review 8.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.

Authors:  Terri E Weaver; Ronald R Grunstein
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

9.  A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.

Authors:  Richard B Berry; Meir H Kryger; Clifford A Massie
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.